The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

H

Huazhong University of Science and Technology

Status

Completed

Conditions

Obesity
Metabolic Disease

Study type

Observational

Funder types

Other

Identifiers

NCT03164005
2016CFA025

Details and patient eligibility

About

The investigators will enroll about 120 subjects from the hospital's healthcare center. The investigators will collect the basic informations, blood pressure, body mass index, fasting blood glucose and fasting blood lipids of each subject. The investigators will collect the blood samples and then test them for fasting insulin levels, VEGF-B levels, the gene promoter region methylation status and the genomic protein methylation levels of the VEGF-B gene of the cells,and finally do the statistical analysis.

Full description

The investigators will enroll about 120 subjects from the hospital's healthcare center, and these 120 subjects will be divided into four groups: normal weight with or without metabolic diseases and obesity with or without metabolic diseases. Each group has 30 subjects. The investigators will collect the basic information(name, gender,age, medical history,family history, etc.), blood pressure, body mass index, fasting blood glucose and fasting blood lipids of each subject from the healthcare center. The investigators will collect the blood samples of each subject,separate the plasma and then test the fasting insulin, VEGF-B levels by ELISA. The investigators will separate the peripheral blood mononuclear cells from the blood, and then test the gene promoter region methylation status of the VEGF -B gene by PCR and the bisulfite-modified sequencing and test the genomic protein methylation level of the VEGF-B gene by chromatin immunoprecipitation assay(CHIP) and real-time quantitative PCR of the cells,and finally do the statistical analysis.

Enrollment

194 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

NA

Exclusion criteria

subjects with active history insulin treatment; and female participant pregnant at the time of recruitment.

Trial design

194 participants in 2 patient groups

Group 1
Description:
subjects without metabolic diseases
Group 2
Description:
subjects with metabolic diseases

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems